ARK Genomic Revolution ETF vs Fabrinet — how do they compare? ARK Genomic Revolution ETF trades at $44.9, while Fabrinet trades at $567.93 (market cap $18.84B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Fabrinet nearer its low. Which is the better fit depends on your goals.
| ARKG | FN | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $746.47 |
52-Week Low | $24.02 | $277.04 |
Market Cap | — | $18.84B |
Enterprise Value | — | $17.90B |
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Fabrinet provides advanced optical and electromechanical manufacturing services to original equipment manufacturers. It specializes in complex products for telecom, automotive, and medical industries.
Read more on FN →